Michelle B. Smit

Associate

芝加哥 + 1.312.269.1565

聯絡

*Share

Michelle Smit advocates for technology and life sciences clients in high-stakes patent and trade secret disputes. She has significant litigation experience where she excels at distilling complex and scientific concepts for judges and juries. In the last four years, Michelle has tried three such cases before juries in federal court.

Michelle represented a pharmaceutical company in patent litigation involving a method of treating non-small cell lung cancer. The jury awarded more than $100 million to Jones Day's client.

She is experienced in all stages of litigation, including conducting internal investigations, drafting complaints, taking and defending fact and expert depositions, and briefing and arguing motions.

Beyond her intellectual property practice, Michelle maintains an active pro bono practice representing asylum seekers through the Firm's Border Project. Before joining Jones Day, Michelle worked as a Public Interest Law Initiative Fellow for Equip for Equality, a nonprofit that protects the human and civil rights of people with disabilities, and served as a law clerk to Judge Kenneth F. Ripple of the U.S. Court of Appeals for the Seventh Circuit. She is a member of the Ravinia Associates Board that is dedicated to promoting the musical arts in Chicago.

執業經驗

  • AbbVie alleges former scientist and his new employer stole trade secrets relating to Bruton's tyrosine kinase (BTK) degradersJones Day is representing AbbVie Inc. in asserting claims for trade secret misappropriation under the Defend Trade Secrets ACT (DTSA) against its former scientist and his new employer, BeiGene, a pharmaceutical company located in China.
  • Pharmaceutical company wins $107.5 million jury verdict in patent dispute involving AstraZeneca's lung cancer treatment Tagrisso®Jones Day on behalf of a pharmaceutical company won a jury award of $107.5 million in damages after a five-day trial and less than three hours of jury deliberation.
  • R.J. Reynolds successfully enforces patents in ITC trial against Philip Morris in dispute over cigarette alternativeJones Day's client Reynolds achieved a precedent-setting victory before the International Trade Commission (ITC) against its main competitors Philip Morris Products S.A. ("Philip Morris") and Altria Client Services LLC ("Altria") in a patent infringement dispute involving tobacco heating and vaping products.
  • Daikin wins IPRs and successfully resolves patent dispute involving fluoropolymer products on eve of trialJones Day represented Daikin Industries, Ltd. and Daikin America, Inc. in a patent infringement suit brought by Chemours Company FC, LLC in Delaware federal court.
  • YS Garments wins complete dismissal of trademark cancellation appeal and renewed trademark infringement claims brought by purported sportswear apparel competitorJones Day successfully defended YS Garments, LLC ("YS Garments"), a leading designer and supplier of fashion blanks, in securing a complete dismissal of both an appeal from the U.S. Trademark Trial and Appeal Board's order cancelling a trademark registration owned by Next Level Sportsystems and Sierra Sportswear (collectively, “NLS”) and NLS's renewed allegations of trademark infringement, false advertising, and deceptive trade practices by YS Garments.
  • Qualcomm defends Apple's patent infringement claims relating to processor power saving techniquesJones Day defended Qualcomm Incorporated against Apple, Inc.'s allegations that Qualcomm's Snapdragon processors – CPU/GPU/Baseband Modem System on Chip – infringe a number of Apple's patents directed to power saving techniques for use in processors.
    •

    June 2019 Jones Day Publications

    Supreme Court Holds Immoral and Scandalous Trademarks Are Registrable

    June 2019 Alert

    Supreme Court Holds Immoral and Scandalous Trademarks Are Registrable

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.